AR067008A1 - Derivados 3- amino-6-(1- amino - etil)-tetrahidropirano - Google Patents
Derivados 3- amino-6-(1- amino - etil)-tetrahidropiranoInfo
- Publication number
- AR067008A1 AR067008A1 ARP080102542A ARP080102542A AR067008A1 AR 067008 A1 AR067008 A1 AR 067008A1 AR P080102542 A ARP080102542 A AR P080102542A AR P080102542 A ARP080102542 A AR P080102542A AR 067008 A1 AR067008 A1 AR 067008A1
- Authority
- AR
- Argentina
- Prior art keywords
- amino
- substituted
- phenyl group
- group
- halogen
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- -1 di-substituted phenyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical group O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente se relaciona con compuestos antibacterianos de formula (1) en la cual R1 representa halogeno o alcoxilo; U y W cada uno representa N, V representa CH y R2 representa H o F, o U y V cada uno representa CH, W representa N y R2 representa H o F, o U representa N, V representa CH, W representa CH o CRa y R2 representa H, o también, cuando W representa CH, puede representar F; Ra representa CH2OH o alcoxicarbonilo; A representa el grupo CH=CH-B, un sistema heterocíclico binuclear D, un grupo fenilo que está mono-substituido en la posicion 4 por alquilo, o un grupo fenilo que está di-substituido en las posiciones 3 y 4, en donde cada uno de los substituyentes es seleccionado de manera independiente de entre alquilo y halogeno, B representando un grupo fenilo mono- o di-substituido en donde cada substituyente es un átomo halogeno y D representando el grupo de formula (2) en el cual Z representa CH o N, y Q representa O o S, y con sales de tales compuestos. Composicion farmacéutica y uso para infeccion bacteriana.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2007052301 | 2007-06-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR067008A1 true AR067008A1 (es) | 2009-09-30 |
Family
ID=39772866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080102542A AR067008A1 (es) | 2007-06-15 | 2008-06-13 | Derivados 3- amino-6-(1- amino - etil)-tetrahidropirano |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8193179B2 (es) |
| EP (1) | EP2167494B1 (es) |
| JP (1) | JP5274553B2 (es) |
| KR (1) | KR101538814B1 (es) |
| CN (1) | CN101711243B (es) |
| AR (1) | AR067008A1 (es) |
| AT (1) | ATE520687T1 (es) |
| AU (1) | AU2008263397B2 (es) |
| BR (1) | BRPI0812942B1 (es) |
| CA (1) | CA2689102C (es) |
| ES (1) | ES2370123T3 (es) |
| MX (1) | MX2009013254A (es) |
| PL (1) | PL2167494T3 (es) |
| TW (1) | TWI414290B (es) |
| WO (1) | WO2008152603A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009104147A2 (en) | 2008-02-20 | 2009-08-27 | Actelion Pharmaceuticals Ltd | Azatricyclic antibiotic compounds |
| BRPI0913093A2 (pt) * | 2008-06-03 | 2018-02-06 | Actelion Pharmaceuticals Ltd | Compostos derivados de [4-(1-amino-etil)-cicloexil]- metil-amina e [6-(1-amino-etil)-tetraidro-piran-3-il]- metil-amina, medicamento, composição farmacêutica que contêm esse composto e uso dos mesmos |
| CN104151316B (zh) | 2008-10-07 | 2016-06-15 | 埃科特莱茵药品有限公司 | 三环噁唑烷酮抗生素化合物 |
| MX2011005905A (es) * | 2008-12-12 | 2011-06-20 | Actelion Pharmaceuticals Ltd | Derivados de 5-amino-2-(1-hidroxi-etil)-tetrahidropirano. |
| ES2578182T3 (es) | 2011-05-31 | 2016-07-21 | Actelion Pharmaceuticals Ltd. | Procedimientos de preparación de intermediarios sintéticos que pueden usarse para la fabricación de antibióticos |
| AU2012275499A1 (en) * | 2011-06-27 | 2013-12-19 | Kyorin Pharmaceutical Co., Ltd. | Bridged bicyclic compounds for the treatment of bacterial infections |
| CN106083787B (zh) * | 2016-06-21 | 2018-05-04 | 济南川成医药科技开发有限公司 | 一种4-(2-氨乙基)四氢吡喃的合成方法 |
| US9957233B1 (en) | 2016-08-05 | 2018-05-01 | Calitor Sciences, Llc | Process for preparing substituted quinolin-4-ol compounds |
| TW201833120A (zh) | 2017-02-17 | 2018-09-16 | 瑞士商愛杜西亞製藥有限公司 | 芳基噁唑啶酮抗生素化合物 |
| CR20200054A (es) | 2017-08-09 | 2020-03-21 | Denali Therapeutics Inc | Compuestos, composiciones y métodos |
| PT3676297T (pt) | 2017-09-01 | 2023-08-29 | Denali Therapeutics Inc | Compostos, composições e métodos |
| US12091392B2 (en) | 2019-02-13 | 2024-09-17 | Denali Therapeutics Inc. | Compounds, compositions and methods |
| TWI877136B (zh) | 2019-02-13 | 2025-03-21 | 美商戴納立製藥公司 | 化合物、組合物及方法 |
| GB201904469D0 (en) | 2019-03-29 | 2019-05-15 | Givaudan Sa | Cosmetic composition |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2816618B1 (fr) | 2000-11-15 | 2002-12-27 | Aventis Pharma Sa | Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent |
| BR0315221A (pt) * | 2002-10-10 | 2005-08-23 | Morphochem Ag Komb Chemie | Compostos com atividade antibacteriana |
| WO2006012396A1 (en) * | 2004-07-22 | 2006-02-02 | Glaxo Group Limited | Antibacterial agents |
| DE102004041163A1 (de) * | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
| CA2580621A1 (en) | 2004-09-24 | 2006-03-30 | Actelion Pharmaceuticals Ltd | New bicyclic antibiotics |
| WO2006046552A1 (ja) | 2004-10-27 | 2006-05-04 | Toyama Chemical Co., Ltd. | 新規な含窒素複素環化合物およびその塩 |
| CN101258157A (zh) | 2005-05-24 | 2008-09-03 | 阿斯利康(瑞典)有限公司 | 具有抗菌活性的氨基哌啶喹啉及其氮杂等构类似物 |
| ATE536351T1 (de) * | 2006-01-26 | 2011-12-15 | Actelion Pharmaceuticals Ltd | Tetrahydropyran-antibiotika |
| CA2643962A1 (en) * | 2006-03-10 | 2007-09-20 | Actelion Pharmaceuticals Ltd | Antibiotic compounds |
-
2008
- 2008-06-13 CA CA2689102A patent/CA2689102C/en not_active Expired - Fee Related
- 2008-06-13 CN CN2008800187896A patent/CN101711243B/zh not_active Expired - Fee Related
- 2008-06-13 PL PL08763320T patent/PL2167494T3/pl unknown
- 2008-06-13 ES ES08763320T patent/ES2370123T3/es active Active
- 2008-06-13 BR BRPI0812942A patent/BRPI0812942B1/pt not_active IP Right Cessation
- 2008-06-13 AT AT08763320T patent/ATE520687T1/de active
- 2008-06-13 JP JP2010511771A patent/JP5274553B2/ja not_active Expired - Fee Related
- 2008-06-13 KR KR1020107000842A patent/KR101538814B1/ko not_active Expired - Fee Related
- 2008-06-13 AR ARP080102542A patent/AR067008A1/es unknown
- 2008-06-13 US US12/664,828 patent/US8193179B2/en not_active Expired - Fee Related
- 2008-06-13 WO PCT/IB2008/052333 patent/WO2008152603A1/en not_active Ceased
- 2008-06-13 TW TW097122296A patent/TWI414290B/zh not_active IP Right Cessation
- 2008-06-13 EP EP08763320A patent/EP2167494B1/en not_active Not-in-force
- 2008-06-13 MX MX2009013254A patent/MX2009013254A/es active IP Right Grant
- 2008-06-13 AU AU2008263397A patent/AU2008263397B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2689102A1 (en) | 2008-12-18 |
| EP2167494B1 (en) | 2011-08-17 |
| CN101711243A (zh) | 2010-05-19 |
| JP2010529983A (ja) | 2010-09-02 |
| WO2008152603A1 (en) | 2008-12-18 |
| JP5274553B2 (ja) | 2013-08-28 |
| CN101711243B (zh) | 2013-01-09 |
| ATE520687T1 (de) | 2011-09-15 |
| KR101538814B1 (ko) | 2015-07-22 |
| BRPI0812942A8 (pt) | 2018-05-02 |
| TW200906416A (en) | 2009-02-16 |
| ES2370123T3 (es) | 2011-12-12 |
| US20100179135A1 (en) | 2010-07-15 |
| BRPI0812942B1 (pt) | 2018-11-21 |
| AU2008263397B2 (en) | 2013-12-05 |
| US8193179B2 (en) | 2012-06-05 |
| MX2009013254A (es) | 2010-01-25 |
| PL2167494T3 (pl) | 2012-01-31 |
| CA2689102C (en) | 2016-07-26 |
| RU2010101003A (ru) | 2011-07-20 |
| BRPI0812942A2 (pt) | 2014-12-16 |
| EP2167494A1 (en) | 2010-03-31 |
| KR20100023031A (ko) | 2010-03-03 |
| TWI414290B (zh) | 2013-11-11 |
| AU2008263397A1 (en) | 2008-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR067008A1 (es) | Derivados 3- amino-6-(1- amino - etil)-tetrahidropirano | |
| AR060401A1 (es) | Derivados de cromen-2-ona | |
| AR052568A1 (es) | Derivados de pirazolo -pirimidina como antagonstas de mglur2 | |
| CL2012000999A1 (es) | Compuestos derivados de pirazoloespirocetona sustituida, inhibidores de acetil-coa carboxilasa; composicion farmaceutica que los comprende; uso para tratar o retrasar la progresion o el inicio de diabetes tipo 2, higado graso no alcoholico (hgna) o la resistencia hepatica a la insulina. | |
| CO6251261A2 (es) | Derivados de 1- 82-amino-2-oxoalquil)-n(1h-indazol-5-il)pirrolidina-3-carboxamida | |
| AR056964A1 (es) | Derivados de aminosulfonilo, composiciones farmaceuticas y sus usos | |
| ES2668775T3 (es) | Compuestos tetracíclicos | |
| CO6300864A2 (es) | Derivados polisustituidos de 6-heteroaril-imidazo[1,2-a]piridinas su preparacion y su aplicacion en terapeutica | |
| AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR039665A1 (es) | Fenilacetamidas sustituidas y su uso como activadores de glucoquinasa | |
| AR060807A1 (es) | Derivados de arilaminopiridina heteroaril - susutituidos como inhibidores de mek | |
| EA201170096A1 (ru) | Замещенные производные пиримидона | |
| AR074109A1 (es) | Pirrolidinas heterociclicas agonistas de receptores de la melanocortina, composiciones farmaceuticas que las contienen y uso de las mismas en el tratamiento de la obesidad, diabetes y disfuncion erectil. | |
| AR050540A1 (es) | Derivados de adamantilamida triciclica como inhibidores de deshidrogenasa 11- beta hidroxiesteroide | |
| AR053569A1 (es) | Derivados de pirazol | |
| AR082562A1 (es) | Derivados de isoxazolina como agentes antiparasitarios | |
| PE20081754A1 (es) | Complejos cristalinos de compuestos organicos activos para uso agricola | |
| AR073043A1 (es) | Compuestos de azetidinas polisustituidos, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de los mismos en el tratamiento de enfermedades respiratorias, metabolicas y del sistema nervioso central, entre otras. | |
| CY1115643T1 (el) | Διεγερτης νευρογενεσης ή θεραπευτικος παραγων νευροπαθειας που περιλαμβανει παραγωγα αλκυλ αιθερα ή αλας αυτου | |
| AR103742A1 (es) | Derivados de trifluorometilpropanamida | |
| AR054232A1 (es) | Derivados de piridina -2- carboxamida como antagonistas de mglur5 | |
| AR049418A1 (es) | Derivados de heteroarilaminopirazol y composiciones farmaceuticas para el tratamiento de la diabetes. | |
| AR064488A1 (es) | DERIVADOS DE4-(1-AMINO-ETIL)-CICLOHEXILAMINA, UNA COMPOSICION FARMACEUTICA QUE LO CONTIENE Y EL USO DE LOS MISMOS PARA LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO O PREVENCIoN DE UNA INFECCION BACTERIANA | |
| AR083861A1 (es) | OXAZOLIDINONAS COMO MODULADORES DE mGluR5 Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN | |
| AR069781A1 (es) | Compuestos de n-(2,3-dihidro-inden-2-il) propanosulfonamida, composicion farmaceutica que los comprenden y su uso para el tratamiento de la ezquizofrenia. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |